Mohammad Jaber, MD
Vascular Surgery · West Covina, CANPI 1407980410
Payments from drug & device makers
What this record shows
This record is dominated by other: $52,063 of the $57,454 with a category attached, or 90.6%. Angiodynamics, Inc. accounts for 90.6% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $30,571, more than ten times the $2,667 reported in 2019. Among vascular surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $692.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$52K
- Silk Road Medical, Inc.$2K
- Cardiovascular Systems Inc.$1K
- Cook Medical LLC$305
- Johnson & Johnson$266
- Medtronic$266
- plus $2K from 19 others
What the payments were for
- Travel & lodging$2,4334%
- Food & beverage$2,9585%
- Other$52,06391%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 7 | $52,063 |
| Silk Road Medical, Inc. | 12 | $1,733 |
| Cardiovascular Systems Inc. | 2 | $1,129 |
| Cook Medical LLC | 7 | $305 |
| Johnson & Johnson | 13 | $266 |
| Medtronic(2 entities) | 2 | $266 |
| Bard Peripheral Vascular, Inc. | 4 | $225 |
| Endologix LLC | 5 | $219 |
| W. L. Gore & Associates, Inc. | 2 | $164 |
| Laminate Medical Technologies Inc. | 1 | $158 |
| Lemaitre Vascular, Inc. | 3 | $151 |
| Bolton Medical Inc | 2 | $119 |
| Penumbra, Inc. | 1 | $118 |
| Organogenesis Inc. | 1 | $101 |
| Tactile Systems Technology Inc | 5 | $89 |
| Smith+Nephew | 5 | $84 |
| Biotissue Holdings Inc. | 1 | $73 |
| Livanova USA, Inc. | 3 | $59 |
| Cardiva Medical, Inc. | 1 | $22 |
| Integra Lifesciences Corporation | 1 | $21 |
| Bsn Medical Inc | 1 | $19 |
| Merck | 1 | $19 |
| Innocoll Pharmaceuticals Limited | 1 | $17 |
| Biocompatibles, Inc. | 1 | $17 |
| Medline Industries LP | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$52,063
- ENROUTE Transcarotid Neuroprotection System$2,306
- Peripheral Orbital Atherectomy System$1,080
- ENROUTE Transcarotid Stent$783
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$783
- ENROUTE Transcarotid Stent System$740
- ENHANCE Transcarotid Peripheral Access Kit$740
- ENROUTE 0.014 Guidewire$740
- VasQ External Support$158
- Valiant Captivia$141
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$140
- KYPHON Balloon Kyphoplasty$125
- ARTEGRAFT VASCULAR GRAFT$125
- Penumbra System$118
- WAVELINQ$118
- RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM$104
- PuraPly$101
How this compares
$57,454 in reported general payments places this provider in the 90th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 17 | $13,238 |
| EliquisApixaban | 14 | $10,673 |
| ClopidogrelClopidogrel Bisulfate | 46 | $504 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $163 |
| Cephalexin | 16 | $86 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $266 | $13,23817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 519 vascular surgery providers in California.
Other vascular surgery in West Covina
- Son DuongFountain Valley$503K
- Venita ChandraPalo Alto$488K
- Sukgu HanLos Angeles$477K
- Leigh Ann ObanionFresno$469K
- Trevor DerderianRancho Mirage$359K
- Karthikeshwar KasirajanPalo Alto$349K
- Johnathon RolloLos Angeles$337K
- Melissa LojaFairfield$272K
- Jason LeePalo Alto$228K
- John LaneSan Diego$212K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.